Physicochemical and pharmacodynamic evaluation of pioglitazone binary systems with hydrophilic carriers

References

• Abd Elbary A, Kassem MA, Abou Samra MM, Khalil RM. 2008. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes. Drug Discov Ther. 2:94–107.
   PubMedGoogle Scholar
• Alamin MA, Yagi AI, Yagi SM. 2015. Evaluation of antidiabetic activity of plants used in Western Sudan. Asian Pac J Trop Biomed. 5:395–402.
   Google Scholar
• Al-Rasheed NM, Al-Rasheed NM, Al-Amin MA, Hasan IH, Al-Ajmi HN, Mohammad RA, Attia HA. 2016. Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat’s model via suppression of augmented TGF-b1/Smad3 signaling pathway. Arch Physiol Biochem. 122:186–194.
   PubMed Web of Science ®Google Scholar
• Arora MK, Reddy K, Balakumar P. 2010. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy. Eur J Pharmacol. 636:137–144.
   PubMed Web of Science ®Google Scholar
• Bartels H, Böhmer M, Heierli C. 1972. Serum creatinine determination without protein precipitation. Clin Chim Acta. 37:193–197.
   PubMed Web of Science ®Google Scholar
• Cavallari C, Rodriguez L, Albertini B, Passerini N, Rosetti F, Fini A. 2005. Thermal and fractal analysis of diclofenac/Gelucire 50/13 microparticles obtained by ultrasound-assisted atomization. J Pharm Sci. 94:1124–1134.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Quilley J. 2008. Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release. J Pharmacol Exp Ther. 324:658–663.
   PubMed Web of Science ®Google Scholar
• Craig D. 2002. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 231:131–144.
   PubMed Web of Science ®Google Scholar
• Date AA, Vador N, Jagtap A, Nagarsenker MS. 2011. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery. Nanotechnology. 22:275102.
   PubMed Web of Science ®Google Scholar
• DeMerlis CC, Schoneker DR. 2003. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol. 41:319–326.
   PubMed Web of Science ®Google Scholar
• Dordunoo SK, Ford JL, Rubinstein MH. 1991. Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or gelucire 44/14 for liquid filling of hard gelatin capsules. Drug Dev Ind Pharm. 17:1685–1713.
   Web of Science ®Google Scholar
• Douroumis D, Bouropoulos N, Fahr A. 2007. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. J Pharm Pharmacol. 59:645–653.
   PubMed Web of Science ®Google Scholar
• EL-Badry M, Alanazi FK, Mahrous GM, Alsarra IA. 2010. Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules . Pharm Dev Technol. 15:500–510.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fathy M. 2004. Properties of solid dispersions of piroxicam in pluronic F-98. J Drug Del Sci Technol. 14:199–205.
   Web of Science ®Google Scholar
• El-Badry M, Fathy M. 2006. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polvvinylpyrrilidone K-30. Drug Dev Ind Pharm. 32:41–150.
   Web of Science ®Google Scholar
• Fouad EA, EL-Badry M, Mahrous GM, Alanazi FK, Neau SH, Alsarra IA. 2011. The use of spray-drying to enhance celecoxib solubility. Drug Dev Ind Pharm. 37:1463–1472.
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, El-Badry M. 2014. Formulation of immediate release pellets containing famotidine solid dispersions. Saudi Pharm J. 22: 149–156.
   PubMed Web of Science ®Google Scholar
• Janssens S, Anne M, Rombaut P, Van den Mooter G. 2009. Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions. Eur J Pharm Sci. 37:241–248.
   PubMed Web of Science ®Google Scholar
• Janssens S, Novoa de Armas H, Remon JP, Van den Mooter G. 2007. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole. Eur J Pharm Sci. 30:288–294.
   PubMed Web of Science ®Google Scholar
• Khan KA. 1975. The concept of dissolution efficiency. J Pharm Pharmacol. 27:48–49.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 50:47–60.
   PubMed Web of Science ®Google Scholar
• Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. 2010. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 1:149–173.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA. 2001. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care. 24:710–719.
   PubMed Web of Science ®Google Scholar
• Passerini N, Perissutti B, Moneghini M, Voinovich D, Albertini B, Cavallari C, Rodriguez L. 2002. Characterization of carbamazepine–gelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds. J Pharm Sci. 91:699–707.
   PubMed Web of Science ®Google Scholar
• Shazly GA, Ibrahim MA, Badran MM, Zoheir K. 2012. Utilizing pluronic F 127 and gelucire 50/13 solid dispersions for enhanced skin delivery of flufenamic acid. Drug Dev Res. 73:299–307.
   Web of Science ®Google Scholar
• Sutananta W, Craig DQM, Newton JM. 1994. The effects of ageing on the thermal behavior and mechanical properties of pharmaceutical glycerides. Int J Pharm. 111:51–62.
   Web of Science ®Google Scholar
• Tripathi KD. editor. 2003. Antidiabetic drugs. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers Ltd; p. 345–352.
   Google Scholar
• Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. 2013. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage – impact of different polymers. J Pharm Sci. 102:171–184.
   PubMed Web of Science ®Google Scholar